Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans

• Status: Completed
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will investigate the performance of physician readers trained to read florbetapir-PET scans using electronic media training.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Avid Radiopharmaceuticals

Criteria

Eligibility for subjects scans to be used in this study is determined by subject's eligibility/enrollment in Study A05 (NCT00702143) or A07 (NCT00857415).

Alzheimer's disease (AD) group key eligibility criteria (from Study A05[NCT00702143]):

• Male or female at least 50 years of age

• Have probable AD per National Institute of Neurological and Communication Disorders and Stroke (NINCDS) criteria

• Mini mental state exam (MMSE) score between 10 and 24 inclusive

Mild cognitive impairment group key eligibility criteria (from Study A05[NCT00702143):

• Male or female at least 50 years of age

• Complaints of memory or cognitive decline corroborated by an informant

• Clinical dementia rating of 0.5

• No obvious cause for cognitive impairment (eg, head trauma or stroke)

• Cognitive impairment onset within the past year

• MMSE score greater than 24

Cognitively normal volunteer group key eligibility criteria (from Study A05[NCT00702143]):

• Male or female at least 50 years of age

• MMSE score greater than or equal to 29 and cognitively normal by informant report and psychometric test battery at screening

Autopsy cohort key eligibility criteria (from Study A07[NCT00857415]):

• Male or female 18 years or older

• Projected life expectancy of less than 6 months

• Consent to brain donation